“The right provider isn’t just about convenience—it’s about clinical safety, transparency, and a plan that puts your health first.”
📑 Table of Contents
⚡ TL;DR: Where to Get GLP-1 Medication
You can access GLP-1 medications through three main routes: your primary care provider, a specialist in obesity medicine, or a telehealth platform [citation:5]. The safest and most reliable source is a licensed clinician who provides ongoing monitoring and comprehensive care [citation:1][citation:5][citation:6].
🔍 Find a Trusted Provider Today
📍 Your Options for Accessing GLP-1 Medications
1. Your Primary Care Provider (PCP)
Your PCP is often the best starting point. They know your medical history and can assess whether GLP-1 therapy is appropriate based on your BMI, health conditions, and risk factors [citation:5][citation:11]. Eligibility criteria typically include a BMI ≥30, or ≥27 with a weight-related condition like type 2 diabetes, high blood pressure, or high cholesterol [citation:5][citation:11].
2. Obesity Medicine Specialists
Specialists in endocrinology, cardiology, or bariatric medicine often have deeper experience with GLP-1 therapies. Many academic medical centers now offer dedicated weight management clinics that combine medical supervision with nutritional and behavioral support [citation:5].
3. Telehealth Platforms
Telehealth has revolutionized access, offering convenience and speed. In a recent analysis of Reddit posts, patients reported getting GLP-1 prescriptions from dozens of telehealth platforms [citation:2]. However, the quality of care varies widely—some platforms offer robust clinical support, while others provide minimal oversight [citation:2][citation:7].
🏅 Top Telehealth Platforms for GLP-1s (2026 Ratings)
U.S. News & World Report recently released its first-ever ratings of telehealth platforms offering FDA-approved GLP-1s [citation:3][citation:8]. They evaluated 20 platforms across six pillars: clinical support, screening rigor, transparency, insurance assistance, supplemental care, and customer satisfaction [citation:3].
| Platform | Rating (out of 5) | Best For |
|---|---|---|
| Amazon One Medical | 4.8 | Insurance Support |
| Found | 4.6 | Clinical Support |
| Mochi Health | 4.4 | Overall Value |
| Ro | 4.4 | Customer Satisfaction |
| Noom | 4.3 | Supplemental Coaching |
| PlushCare | 4.1 | Convenience |
| WeightWatchers | 3.9 | Integrated Lifestyle Support |
Note: Platforms that only offer compounded GLP-1s were not included in the ratings. Some top-rated platforms offer both branded and compounded options [citation:3][citation:8].
⚖️ Compounded vs. FDA-Approved GLP-1s: What You Need to Know
Why Compounded Versions Exist
Compounding pharmacies began producing GLP-1s during official drug shortages. However, the FDA has declared the shortages for tirzepatide and semaglutide resolved [citation:4]. Yet, compounded versions remain on the market, often marketed at lower prices [citation:4][citation:9].
The Risks
- Dosing Errors: The FDA has received reports of patients accidentally taking 5- to 20-times the intended dose due to confusing measurement units [citation:13]. Some patients required hospitalization [citation:2][citation:13].
- Unpredictable Quality: Even small differences in formulation can affect absorption, purity, and clinical response [citation:9].
- Immunogenicity Risk: Patients may develop antibodies to their own GLP-1 if the compounded version is not identical [citation:4].
- No Safety Net: Unlike FDA-approved drugs, compounded products lack postmarket surveillance and clear safety signals [citation:4].
🔥 Ready to Start Safely?
🚩 Red Flags: When a Program Is Unsafe
Experts from the Obesity Medicine Association and FDA warn against programs that display these signs [citation:4][citation:9]:
- ✗ Claims a compounded product is “equivalent” or “same as” FDA-approved
- ✗ No named, licensed clinician
- ✗ No medical history or medication review
- ✗ Vague or missing pharmacy identity
- ✗ Unusually low pricing that seems disconnected from legitimate supply chains [citation:9]
- ✗ Non-standard dosing instructions or unclear measurement units [citation:13]
❓ FAQs
You can get GLP-1 medication from your primary care provider, an obesity medicine specialist, or a top-rated telehealth platform that offers licensed clinician oversight, thorough screening, and ongoing monitoring [citation:1][citation:5][citation:3].
Typically, GLP-1s are prescribed for adults with a BMI ≥30, or ≥27 with weight-related conditions like type 2 diabetes, high blood pressure, or high cholesterol [citation:5][citation:11]. A healthcare provider will evaluate your full medical history before prescribing [citation:5].
Yes, if you choose a telehealth platform with high clinical standards. U.S. News recently rated 11 telehealth platforms as top performers, including Amazon One Medical, Found, and Ro [citation:3][citation:8]. Ensure the platform offers real-time clinician interaction, thorough screening, and a clear follow-up plan [citation:3].
FDA-approved GLP-1s (Wegovy, Zepbound) have undergone rigorous testing for safety, efficacy, and quality. Compounded versions are not FDA-approved and may have dose variability, impurities, or inconsistent absorption [citation:4][citation:9].
Yes, many reputable telehealth platforms offer virtual consultations with licensed providers who can prescribe GLP-1s after a thorough medical evaluation [citation:3][citation:5]. Some experts recommend video visits over asynchronous chats for better clinical oversight [citation:3].
Did you know? Many top-rated platforms now offer transparent pricing, HSA/FSA acceptance, and month-to-month plans. Your health is worth the investment in safety.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any weight‑loss medication. Compounded drugs are not FDA‑approved; talk to your provider about formulation differences and risks. The ratings and information cited are based on published reports and do not constitute an endorsement.
© 2026 · GLP‑1 Access Guide · Evidence‑based & reader‑first.
